IVVD

Invivyd

0.7286

-0.0778-9.65%

After Hours: 0.7420 +0.0134 +1.84%19:57 10/07 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.8037/0.8064

TODAY RANGE0.7251-0.8200

VOL9.47M

MARKET CAP215.20M

52 WEEK RANGE0.5277-3.070

AVG VOL (3M)4.77M

% TURNOVER3.18%

TURNOVER--

P/E (TTM)-1.9548

% RANGE11.77%

EPS(TTM)-0.3735

P/E(FORWARD)-1.3863

P/B1.189

BVPS0.6143

DIVIDEND--

P/S3.853

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP186.16M

SHARES OUTSTANDING294.76M

NEXT EARNINGS11/04-11/09

FREE FLOAT254.98M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·5d ago
Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data
TipRanks·09/30 10:45
BTIG Sticks to Its Buy Rating for Invivyd (IVVD)
TipRanks·09/29 16:40
Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS)
Seeking Alpha·09/29 16:35
Invivyd drops after delaying late-stage trial data for COVID therapy
TipRanks·09/29 16:30
Invivyd Phase 3 data supports VYD2311 tolerability, says H.C. Wainwright
TipRanks·09/29 11:49
Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety
TipRanks·09/29 11:25
Invivyd announces results from LIBERTY Phase 3 study of VYD2311
TipRanks·09/22 10:10
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)
MarketWatch·09/21 21:06
These beaten-down stocks could bounce back in January, if history is any guide
Dow Jones·09/14 12:35
Invivyd Price Target Maintained With a $10.00/Share by BTIG
TipRanks·09/09 16:30
Invivyd management to meet virtually with BTIG
TipRanks·09/01 14:45
Cantor says Invivyd should be trading ‘meaningfully higher’ after update
Seeking Alpha·09/01 13:31
Invivyd names Marc Elia CEO
NASDAQ·09/01 12:49
Invivyd Names Chairman Marc Elia CEO, Adds New Directors
TipRanks·09/01 11:27
Invivyd appoints Marc Elia CEO amid board reshuffle

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-0.56%

874.65

Biogen Inc

BIIB

+0.55%

227.60

Amgen Inc

AMGN

-3.38%

407.27

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-12.41%

0.1094

Lilly Eli & Co

LLY

+0.04%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

+0.46%

2.190

Johnson & Johnson

JNJ

-0.10%

269.19

Abbvie Inc

ABBV

-0.02%

263.96

Zoetis Inc

ZTS

+0.54%

71.44

Gilead Sciences Inc

GILD

-1.87%

144.74

Novo-Nordisk A/S

NVO

+0.47%

38.80

Bristol-Myers Squibb Co

BMY

-0.70%

62.62

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+0.29%

27.74

Sanofi FR

SNY

+0.42%

41.11

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+1.32%

145.46

Dr Reddys Labs

RDY

0.00%

12.19

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.